🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Temporomandibular disorder (TMD) is a common musculoskeletal pain condition...
Status
Not Yet Recruiting
Location
Beijing Hospital of Traditional Chinese Medicine
Start Date
2025-06-01
Trial ID
NCT06738667
Treatments Being Tested
This phase III trial compares whether the addition of pembrolizumab to radi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-04-09
Trial ID
NCT04214067
This case control study will be done at Rheumatology Department, Assiut Uni...
Status
Not Yet Recruiting
Location
Assuit University
Start Date
2025-10
Trial ID
NCT07173582
Prostate cancer is the second most common type of cancer in men only after ...
Status
Not Yet Recruiting
Location
CHU de Clermont-Ferrand
Start Date
2024-10
Trial ID
NCT06669273
Treatments Being Tested
Lymphatic mapping is a procedure in which all lymph nodes with drainage fro...
Status
Completed
Location
Amsterdam UMC University of Amsterdam
Start Date
2020-07-20
Trial ID
NCT05746156
Treatments Being Tested
Magnetic resonance imaging (MRI) is a noninvasive and non-ionizing (no use ...
Status
Completed
Location
Radiology Department CHU de Rennes
Start Date
2013-04-18
Trial ID
NCT02900339
Treatments Being Tested
To assess if percentage change in 18F-FLT PET/CT quantitative parameters (S...
Status
Completed
Location
UT Southwestern Medical Center
Start Date
2017-12-11
Trial ID
NCT03318497
Magnetic resonance imaging is an important and increasingly prevalent imagi...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2022-02-23
Trial ID
NCT05086263
Treatments Being Tested
This phase I/II trial identifies the best dose and side effects of selinexo...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2021-05-06
Trial ID
NCT04764942
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842